Health & Fitness
Health and Fitness
Health and Fitness
Tue, February 21, 2012
PDL BioPharma to Present at Upcoming Conferences -- INCLINE VILLAGE, Nev., Feb. 21, 2012 /PRNewswire/ --
PDL BioPharma to Present at Upcoming Conferences
INCLINE VILLAGE, Nev., Feb. 21, 2012 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: [ PDLI ]) today announced that John P. McLaughlin, the company's president and chief executive officer, is scheduled to present at the following upcoming conferences:
(Logo: [ http://photos.prnewswire.com/prnh/20110822/SF55808LOGO ])
RBC Capital Markets Global Healthcare Conference
Tuesday, February 28, 2012
2:05 p.m. EST
New York City
Cowen and Company 32nd Annual Health Care Conference
Tuesday, March 6, 2012
10:00 a.m. EST
Boston, Massachusetts
These presentations will be available to interested parties through live and archived audio webcasts. To access the live and subsequently archived webcasts of the presentation, go to the Company's website at [ http://www.pdl.com ] and go to "Company Presentations & Events." Please connect to the website at least 15 minutes prior to the events to allow for any software download that may be necessary. The archived webcasts will be available for seven days following each presentation.
About PDL BioPharma
PDL pioneered the humanization of monoclonal antibodies and, by doing so, enabled the discovery of a new generation of targeted treatments for cancer and immunologic diseases. Today, PDL is focused on intellectual property asset management, investing in new royalty bearing assets and maximizing the value of its patent portfolio and related assets. For more information, please visit [ www.pdl.com ].
NOTE: PDL BioPharma and the PDL BioPharma logo are considered trademarks of PDL BioPharma, Inc.
SOURCE PDL BioPharma, Inc.
[ Back to top ] RELATED LINKS
[ http://www.pdl.com ]
